Bristol-Myers Squibb Co.

NYSE:BMY  
57.59
-0.22 (-0.38%)
4:11:53 PM EDT: $57.50 -0.09 (-0.16%)
Exchange Changes, Equity Financing / Related, Initial Public Offerings

Ikena Oncology Inc Files For IPO

Published: 03/05/2021 21:00 GMT
Bristol-Myers Squibb Co. (BMY) - Ikena Oncology Inc Files for Ipo of Up to $100 Million – Sec Filing.
Ikena Oncology Inc Says It Intends to Apply to Have Its Common Stock Listed on Nasdaq Global Market Under the Symbol "ikna".
Ikena Oncology Inc Says Credit Suisse, William Blair Are Among Underwriters to Ipo.
Ikena Oncology Inc Says Jefferies, Cowen Are Among Underwriters to Ipo.
Ikena Oncology Inc Says Entities Affiliated With Orbimed Advisors Llc Beneficially Owned 29.45% of Shares Prior to Offering.
Ikena Oncology Inc Says Entities Affiliated With Atlas Venture Beneficially Owned 18.34% of Shares Prior to Offering.
Ikena Oncology Inc Says Entities Affiliated With Fmr Llc Beneficially Owned 9.32% of Shares Prior to Offering.
Ikena Oncology Inc Says Celgene Corporation Beneficially Owned 7.95% of Shares Prior to Offering.
Ikena Oncology Inc Says Proposed Ipo Price is an Estimate Solely for Calculating Sec Registration Fee.